Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):106–112. doi: 10.1097/QAI.0000000000002410

Table 2:

Summary of sleep parameters (median (IQR), assessed via actigraphy, stratified by extent of pain

Overall Pain

None Regional Widespread p-value1

Sleep parameter n 151 189 74

Fragmentation index Average 12.76 (9.53, 16.15) 12.84 (9.73, 16.83) 13.30 (9.76, 16.15) 11.22 (8.12, 14.42) 0.01
Standard deviation 7.96 (6.34, 10.10) 7.56 (6.12, 10.03) 8.46 (6.71, 10.27) 7.88 (5.93, 9.60) 0.12
Maintenance efficiency (%) Average 89.12 (85.21, 91.82) 89.10 (84.68, 91.54) 88.79 (84.98, 91.58) 90.40 (86.30, 93.26) 0.04
Standard deviation 3.55 (2.38, 4.94) 3.58 (2.32, 4.85) 3.59 (2.48, 5.20) 3.19 (2.23, 4.54) 0.23
Sleep duration (mins) Average 424 (384, 459) 424 (389, 459) 421 (383, 450) 440 (384, 475) 0.19
Standard deviation 55 (38, 81) 50 (35, 74) 56 (40, 82) 62.5 (41, 91) 0.04
Sleep onset latency (mins) Average 7 (6, 9) 7 (6, 9) 7 (6, 9) 7 (6, 9) 0.46
Standard deviation 3 (2, 5) 3 (2, 5) 3 (2, 5) 4 (2, 6) 0.11
Wake after sleep onset (mins) Average 53 (38, 73) 53 (40, 75) 55 (39, 73) 47.5 (32, 65) 0.07
Standard deviation 19 (13, 27) 18 (13, 27) 19 (13, 28) 16.5 (12, 26) 0.38
1

p-value obtained from Kruskal-Wallis test;

2

p-value obtained from ANOVA